Cas:23019-38-7 2,5-dichloro-3,6-bis(diethylamino)cyclohexa-2,5-diene-1,4-dione manufacturer & supplier

Chemical Name:2,5-dichloro-3,6-bis(diethylamino)cyclohexa-2,5-diene-1,4-dione

CAS.NO:23019-38-7

Synonyms:2,5-Dichloro-3,6-bis(diethylamino)-p-benzoquinone;2,4-DICHLOROPHENOXY-3,5,6-D3-ACETIC ACID;2,5-Dichlor-3,6-bis-<diethylamino>-1,4-benzochinon;2,5-Dichlor-3,6-bis-diaethylamino-p-benzochinon

Molecular Formula:C₁₄H₂₀Cl₂N₂O₂

Molecular Weight:319.22700

HS Code:2922399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:363.8ºC at 760 mmHg

Density:1.24g/cm3

Index of Refraction:1.546

PSA:40.62000

Exact Mass:318.09000

LogP:2.72260

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,5-Dichloro-3,6-bis(diethylamino)-p-benzoquinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,5-Dichlor-3,6-bis-diaethylamino-p-benzochinon physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-DICHLOROPHENOXY-3,5,6-D3-ACETIC ACID Use and application,diethylamino&gt technical grade,usp/ep/jp grade.

Related News: Wavelength, a more than 30-year-old firm based in Petah Tikva, launched its API CDMO business in early 2020 and currently sports more than 250 customers from 50 countries. N-{5-(3,4-dihydro-2H-quinolin-1-yl)-1-[4-(3,4-dihydro-2H-quinolin-1-yl)-butyl]-pentyl}-benzamide manufacturers A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. Cysteine protease Mch2 isoform alpha (human cell line Jurkat cloneMch5b3 gene Mch2) suppliers Problem is, China is currently focused on reining in healthcare expenditures and might not respond favorably to pricey rare disease meds. 5-(4-fluorophenyl)-2,3-dihydrofuran-2,3-dione vendor & factory.